-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803.P1.33 803. Emerging Diagnostic Tools and Techniques: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
ALL, AML, antibodies, Biological, Leukemia, multiple myeloma, Diseases, Lymphoma (any), Bone Marrow Failure, Therapies, MDS, Non-Hodgkin Lymphoma, Biological Processes, DNA damage, DNA repair, Technology and Procedures, cytogenetics, Plasma Cell Disorders, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, imaging, Quality Improvement , flow cytometry, molecular testing, NGS, RNA sequencing, pathogenesis, WGS
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Fernanda Gutierrez-Rodrigues, PhD1*, Isabel Beerman, PhD2*, Emma M. Groarke, MD1, Bhavisha A Patel, MD1, Nina Spitofsky1*, Diego Quinones Raffo, MSc1*, Sachiko Kajigaya, PhD1*, Luigi Ferrucci, MD, PhD3* and Neal S. Young, MD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2National Institute on Aging, NIH, Baltimore, MD
3National Institute of Aging, Baltimore, MD

Michael Slade, MD, MS1, Michelle O'Laughlin2*, Robert S Fulton2*, Eric J. Duncavage, MD3, Timothy J Ley, MD1, Meagan A. Jacoby, MD1 and David H Spencer, MD1

1Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO
3Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO

Alessandro Gozzetti1*, Donatella Raspadori1*, Paola Pacelli1*, Elisabetta Antonioli, MD2*, Elena Bestoso1*, Sara Ciofini1*, Francesca Bacchiarri, MD1*, Gabriele Buda, MD, PhD3, Dania Tocci1*, Cristiana Cafarelli1*, Anna Marina Liberati4*, Piero Galieni5*, Giulia Lucco Navei1*, Ubaldo Occhini6*, Anna Sicuranza, PhD1*, Michela Staderini2*, Rosaria Crupi1*, Mario Petrini, MD, PhD7, Alberto Bosi, MD8* and Monica Bocchia9*

1Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy
2Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
3Hematology Division, U.O. Hematology, Pisa, Pisa, Italy
4S.C. Oncoematologia, Università degli Studi di Perugia, A.O. Santa Maria, Terni, Italy
5UOC Ematologia e Terapia Cellulare, Ospedale "C. e G. Mazzoni", Ascoli Piceno, Italy
6Hematology, Usl8, Arezzo, ITA
7Hematology Division, U.O.Hematology, Pisa, Pisa, Italy
8SODc Ematologia, AOU Careggi, Firenze, Italy
9Hematology, University of Siena, Siena, Italy

Ben Zion Katz, PhD1,2*, Irit Avivi, MD1,2*, Dan Benisty, MD3*, Shahar Karni, M. Sc.4*, Hadar Shimoni4*, Omri Grooper4* and Olga Pozdnyakova, MD, PhD5*

1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
3Hematology, Tel Aviv Medical Center, Tel Aviv, Israel
4Scopio Labs, Tel Aviv, Israel
5Department of Pathology, Brigham and Women's Hospital, Boston, MA

Wendy N. Erber, MD1,2, Henry Hui, PhD3*, Jason Stanley, BSc (Hons)3*, Thomas Mincherton, BSc3*, Kathryn Clarke, PhD4*, Bradley Augustson, MBBS FRACP FRCPA5,6*, Teng Fong Ng, BSc, MBBS, MRCP7, Chan Yoon Cheah, MBBS8,9, Andrew David McQuillan, MBBS, FRACP, FRCPA10* and Kathy Fuller, PhD3*

1University of Western Australia, Crawley W.A., Australia
2PathWest Laboratory Medicine, Nedlands, Australia
3School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia
4Queen's University, Belfast, United Kingdom
5Department of Haematology, Pathwest QEII Medical Centre, Nedlands, Australia
6Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
7Royal Perth Hospital, Perth, Australia
8University of Western Australia, Crawley, WA, Australia
9Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
10Hollywood Hospital, Nedlands, Australia

Jolien De Bie, MD, PhD1,2*, Barbara Dewaele1*, Olga Gielen3*, Katrina Rack, PhD1*, Johan A. Maertens, MD, PhD4*, Heidi Segers, MD, PhD5*, Joris Vermeesch, PhD1*, Kim De Keersmaecker, PhD6, Jan Cools, PhD7 and Lucienne Michaux, MD, PhD8*

1Center for Human Genetics, Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium
2Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
3Laboratory for Molecular Biology of Leukemia, Department of Human Genetics, Center for Cancer Biology, VIB-KU Leuven, Leuven, Belgium
4Department of Hematology, University Hopitals Leuven, Leuven, Belgium
5Department of Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium
6Laboratory for Disease Mechanisms in Cancer, KU Leuven, Leuven, Belgium
7Laboratory for Molecular Biology of Leukemia, Department of Human Genetics, VIB Center for the Biology of Disease, Leuven, Belgium
8Center for Human Genetics, Department of Human Genetics, University Hospitals Leuven, Leuven, BEL

Martha-Lena Müller, PhD1*, Niroshan Nadarajah1*, Kapil Jhalani1*, Inseok Heo, PhD2*, William Wetton2*, Claudia Haferlach, MD1, Torsten Haferlach, MD1 and Wolfgang Kern, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2Amazon Web Services, Envision Engineering, Herndon

Xinjian Yu1*, Pan Li1*, Heyuan Feng1*, Jian Kang1*, Xichang Zheng1*, Yunmei Zhang1*, Wenhong Yang1*, Tong Wu, MD2 and Shuangyou Liu1*

1Beijing Boren Hospital, Beijing, China
2Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China

Brad B Thomas1*, Yanglong Mou, PhD1*, Lauryn Keeler2*, Christophe Magnan, PhD3*, Vincent Funari, PhD4*, Lawrence Weiss, MD4*, Shari Brown, MD5* and Sally Agersborg, MD, PhD4*

1NeoGenomics Laboratories, Inc., Houston, TX
2NeoGenomics, Carlsbad, CA
3NeoGenomics Laboratories, Inc., Carlsbad, CA
4NeoGenomics Laboratories, Inc., Aliso Viejo, CA
5Neogenomics, Inc., Aliso Viejo, CA

Ehsan Malek, MD1, Jeries Kort, MD2, Gi-Ming Wang, PhD3*, Paolo F Caimi, MD4, Kirsten M Boughan, DO4, Stanton L. Gerson, MD5, Brenda W. Cooper, MD4, Molly M Gallogly, MD, PhD4, Benjamin K. Tomlinson, MD4, Marcos de Lima, MD4, Curtis Tatsuoka, PhD3* and James Driscoll6*

1Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
2University Hospitals Cleveland Medical Center, Cleveland, OH
3Department of Population and Quantitative Health Sciences, Case Western Reserve University, School of Medicine, Cleveland, OH
4Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
5Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
6Case Western Reserve University, Cleveland, OH

Greg Finn, PhD1*, Sandrine Macé2*, Ruiyin Chu3*, Helgi van de Velde, MD, PhD3, Samia Menad4*, Marie-Thérèse Melki, PhD5* and Georges Nouadje4*

1Sanofi R&D, Cambridge, MA
2Sanofi Research and Development, Vitry-Sur-Seine, France
3Sanofi, Cambridge, MA
4Sebia, Lisses, France
5Sebia, Evry, FRA

*signifies non-member of ASH